Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

161 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-19

Study Completion Date

2020-06-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to conduct a two-arm effectiveness trial in Cape Town, South Africa of a Xhosa-adapted, nurse-delivered, cognitive behavioral therapy (CBT) treatment for depression and adherence, integrated into the HIV care setting in patients with HIV who did not achieve viral suppression from first-line treatment. The CBT treatment will be compared to enhanced usual care (Enhanced Treatment As Usual - ETAU) on study endpoints (as described in study endpoints section below).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy

NCT00509340

Depression HIV Infection

TERMINATED PHASE1

Mindfulness and Acceptance Based Therapy for Adolescents Living With HIV

NCT05010317

Medication Adherence Adjustment Reaction With Anxiety and Depression Mental Health Issue

COMPLETED NA

Intervention Development for Syndemics Among PWH in SA

NCT06152003

HIV Infections

NOT_YET_RECRUITING NA

Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b

NCT05352061

Medication Adherence Mental Health Issue

ENROLLING_BY_INVITATION NA

Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV

NCT00602758

HIV Infections Acquired Immunodeficiency Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clinical Clinical depression is one of the highest comorbidities to HIV/AIDS, with estimated rates up to 34.9 percent. Depression, in the context of HIV, leads to poor self-care behavior such as non-adherence to ART and worse retention in care, which are critical for treatment success. Based on our prior work, and given that CBT is an evidenced-based treatment for depression, this is a two-arm effectiveness randomized controlled trial of nurse-delivered cognitive behavioral therapy for depression and adherence integrated into the HIV primary care setting in S. Africa. To ensure that those who need this intervention the most will receive it, participants will be patients with HIV who did not achieve viral suppression from their first line ART, and have a unipolar depressive mood disorder.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immunodeficiency Virus, Human Depressive Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CBT-AD

Those assigned to the CBT-AD \[cognitive behavioral therapy for adherence and depression) condition, will have up to 8 additional sessions delivered by the study clinic nurse. Additionally, those assigned to CBT-AD will have the procedures available to those assigned to ETAU.

Group Type EXPERIMENTAL

Cognitive Behavioral Therapy for Adherence and Depression

Intervention Type BEHAVIORAL

This treatment involves integrating CBT for depression with CBT for adherence following our "Life-Steps" approach.

ETAU

Participants in both conditions receive usual care plus the following procedures below.

All participant will have the benefit of the psychosocial assessment, and the clinic nurse will provide feedback to the participant and to their clinic doctor about their depression. Additionally, all participants will undergo standard of care "second line treatment" adherence counseling in the clinic . The clinic doctor will not be restricted in terms of referral or treatment of depression for their patient with respect to antidepressant medications or other interventions available.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive Behavioral Therapy for Adherence and Depression

This treatment involves integrating CBT for depression with CBT for adherence following our "Life-Steps" approach.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV-seropositive
* Current diagnosis of depression
* Did not attain viral suppression from first-line ARV per local clinic standard

Exclusion Criteria

* Unable or unwilling to provide informed consent.
* Active untreated, major mental illness (untreated psychosis or mania) that would interfere with CBT-AD.
* Has not received CBT for depression.
* Less than 18 years of age.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No